Rearrangements of p300 or CBP with the MOZ gene in AML, namely MOZ-p300 and MOZ-CBP, are associated with the generation of leukemogenic fusion proteins and tumorigenesis [32]. This evidence concerns the gene EP300 and acute myeloid leukemia.